Remy Cointreau

Flabbergasting

25/11/21 -"An exceptional H1 EBIT, with strong beats everywhere, which, for a large part, will drive the FY21-22 EBIT growth. A strong upgrade is expected for consensus’ full-year expectations, although ..."

PDF page sample
Pages
55
Language
English
Published on
25/11/21
Download
You may also be interested by these reports :
22/01/26
Our updated DCF model incorporates the upward adjustments to our EBITDA outlook, including a 1.7% increase for FY25E (previously EUR 302m) and a more ...
22/01/26
Aryzta delivered its trading update, encouraging the market after a period of uncertainty. It highlighted their ability to beat consensus, enhance ...
21/01/26
Barry Callebaut has released its Q1 25/26 results, revealing sales that exceeded expectations, driven solely by price increases. However, volumes ...
19/01/26
The target price remains practically unchanged, considering limited revisions to our estimates. Looking into 2026, the attractiveness of Imperial ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO